We present a case in which plasma pancreatic polypeptide and calcitonin were found to be raised in association with an islet cell tumour of the pancreas and its hepatic metastases. In this patient, no specific endocrine syndrome was found. Therapeutic hepatic artery embolization improved the general health of the patient with no change in plasma pancreatic polypeptide, but a fall in calcitonin.
Introduction
Pancreatic polypeptide (PP), a 36 amino acid peptide, is found principally in small granules in the islets of Langerhans and, to a lesser extent, in the exocrine parenchyma. Its release by food is under both vagal and hormonal control and it is likely to play an important part in the physiological control of pancreatic and gallbladder function (Greenberg et al., 1978) . Over 50% of pancreatic endocrine tumours secrete pancreatic polypeptide in addition to another hormone. In this situation, PP does not seem to contribute to the clinical features of these tumours (Polak et al., 1976) .
Calcitonin, a 32 amino acid peptide, found mainly in the C cells of the thyroid gland, has no clearly defined physiological role in man. It is thought to be important in regulating bone resorption during times of physiological calcium stress such as growth, pregnancy and lactation (Stevenson, 1980 In this situation where there are multiple metastases secreting peptides into the circulation, experience has shown that selective embolization of the arteries supplying the metastases is the optimum line of treatment. This procedure reduces the viability and hormone production of the metastases, resulting in considerable symptomatic improvement (Wood and Bloom, 1982) . The right hepatic artery was therefore embolized using lyophilised human dura mater. This procedure was carried out under local anaesthesia, and the patient given prophylactic antibiotics to prevent the rare complication of hepatic abscess formation.
One month later, the patient was asymptomatic and had gained 5 kg in weight. The plasma PP remained elevated at 40000-50000 pmol/litre, but the plasma calcitonin had fallen to 0 14 ug/litre.
Discussion
It has been shown that infusions of PP resulting in plasma levels comparable with the postprandial plasma concentration of PP inhibit pancreatic enzyme secretion and bile output (Greenberg et al., 1978) . Its elevation in plasma many hours after food has led to the suggestion that PP may play a part in conserving pancreatic enzymes and promoting the storage of bile between meals. There was however no evidence of steatorrhoea or other features of malabsorption in this patient that might have been expected from the effect of PP on pancreatic and bile secretion.
Calcitonin release has been reported from a wide variety of tumours (Coombes et aL, 1974) and the diarrhoea of medullary carcinoma of the thyroid has been attributed to it. Our patient, however, had constipation, despite a grossly elevated plasma calcitonin concentration. This may be explained by PP masking the effect of calcitonin on the gut, since PP has recently been shown to produce a net fluid absorption in the rat small intestine (Mitchenere et aL, 1981) . The patient's other symptoms were those commonly associated with neoplasia, namely malaise, anorexia, and cachexia. These improved considerably after embolization, at a time when his plasma calcitonin had fallen to almost normal, perhaps suggesting an association between the two. 
